SEI Investments’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

SEI Investments’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,242	Closed	-$359K	–	3149
2025 Q3	$359K	Buy	9,242 +3,474	+60%	+$126K	﹤0.01%	2389
2025 Q2	$195K	Buy	5,768 +3,026	+110%	+$95.8K	﹤0.01%	2574
2025 Q1	$87.2K	Sell	2,742 -188	-6%	-$7.13K	﹤0.01%	2620
2024 Q4	$114K	Buy	+2,930	New	+$123K	﹤0.01%	2561

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SEI Investments's GNOM Position: Q4 2025 in Review

SEI Investments sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2025, closing a stake of 9,242 shares — an estimated $359K sold.

SEI Investments first reported a position in GNOM in Q4 2024 and held it in 4 quarters. The position peaked at $359K in Q3 2025. 40 funds tracked by Wall St. Rank hold GNOM as of Q4 2025.

SEI Investments reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
SEI Investments sold 9,242 Global X Genomics & Biotechnology ETF shares in Q4 2025, an estimated $359K.
SEI Investments first reported a position in Global X Genomics & Biotechnology ETF in Q4 2024 and held it in 4 quarters.
SEI Investments's Global X Genomics & Biotechnology ETF position peaked at $359K in Q3 2025.
40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2025.

Based on SEI Investments's 13F filing for Q4 2025, filed 13 Feb 2026.